Recent Finacing
Recent Raise
BlueRock Therapeutics develops iPSC-based regenerative therapies, focusing on cardiovascular and neurodegenerative indications using an iPSC platform licensed from iPS Academia Japan, with R&D in Toronto, New York and Boston.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors